Alterations in lipid levels of mitochondrial membranes induced by amyloid-β: A protective role of melatonin

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  Rosales Corral, Sergio A ^a,b   Lopez Armas, Gabriela ^b   Cruz Ramos, Jose ^b   Melnikov, Valery G ^c   Tan, Dun Xian ^a   Manchester, Lucien C ^a   Munoz, Ruben ^d   Reiter, Russel J ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSIDAD DE COLIMA   (Mexico)

^d UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CHOLESTEROL; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; LIPID; MELATONIN; MEMBRANE LIPID; PALMITIC ACID;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FATTY ACID BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; MEMBRANE FLUIDITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

EID: 84862289157     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/459806     Document Type: Article

References (76)

1. De Pietri Tonelli D., Mihailovich M., Di Cesare A., Codazzi F., Grohovaz F., Zacchetti D., Translational regulation of BACE-1 expression in neuronal and non-neuronal cells Nucleic Acids Research 2004 32 5 1808 1817 (Pubitemid 38832726)
2. Maggio J. E., Mantyh P. W., Brain amyloida physicochemical perspective Brain Pathology 1996 6 2 147 162
3. Yatin S. M., Varadarajan S., Link C. D., Butterfield D. A., In vitro and in vivo oxidative stress associated with Alzheimer's amyloid -peptide (142) Neurobiology of Aging 1999 20 3 325 342
4. Rosales-Corral S., Tan D. X., Reiter R. J., Valdivia-Velzquez M., Martnez-Barboza G., Acosta-Martnez J. P., Ortiz G. G., Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid- peptide in rat brain: a comparative, in vivo study versus vitamin C and E Journal of Pineal Research 2003 35 2 80 84 (Pubitemid 36960345)
5. Lassmann H., Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease Journal of Neural Transmission 2011 118 5 747 752
6. Mitew S., Kirkcaldie M. T. K., Halliday G. M., Shepherd C. E., Vickers J. C., Dickson T. C., Focal demyelination in Alzheimer's disease and transgenic mouse models Acta Neuropathologica 2010 119 5 567 577
7. Brown M. S., Ye J., Rawson R. B., Goldstein J. L., Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans Cell 2000 100 4 391 398
8. Patil S., Sheng L., Masserang A., Chan C., Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons Neuroscience Letters 2006 406 1-2 55 59 (Pubitemid 44278378)
9. Patil S., Chan C., Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons Neuroscience Letters 2005 384 3 288 293 (Pubitemid 40836016)
10. Igarashi M., Ma K., Gao F., Kim H. W., Rapoport S. I., Rao J. S., Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex Journal of Alzheimer's Disease 2011 24 3 507 517
11. Liu Y., Yang L., Conde-Knape K., Beher D., Shearman M. S., Shachter N. S., Fatty acids increase presenilin-1 levels and -secretase activity in PSwt-1 cells Journal of Lipid Research 2004 45 12 2368 2376 (Pubitemid 39602985)
12. Lovell M. A., Xie C., Markesbery W. R., Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease Neurology 1998 51 6 1562 1566 (Pubitemid 28565232)
13. Esterbauer H., Schaur R. J., Zollner H., Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radical Biology and Medicine 1991 11 1 81 128 (Pubitemid 121003917)
14. Kriem B., Sponne I., Fifre A., Malaplate-Armand C., Lozac'h-Pillot K., Koziel V., Yen-Potin F. T., Bihain B., Oster T., Olivier J. L., Pillot T., Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid- peptide The FASEB Journal 2005 19 1 85 87 (Pubitemid 40069926)
15. Lim G. P., Calon F., Morihara T., Yang F., Teter B., Ubeda O., Salem N., Frautschy S. A., Cole G. M., A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model Journal of Neuroscience 2005 25 12 3032 3040 (Pubitemid 40463537)
16. Sahlin C., Pettersson F. E., Nilsson L. N. G., Lannfelt L., Johansson A. S., Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced A levels in cellular models of Alzheimer's disease European Journal of Neuroscience 2007 26 4 882 889 (Pubitemid 47274614)
17. Umezawa M., Kogishi K., Tojo H., Yoshimura S., Seriu N., Ohta A., Takeda T., Hosokawa M., High-linoleate and high- -linolenate diets affect learning ability and natural behavior in SAMR1 mice Journal of Nutrition 1999 129 2 431 437 (Pubitemid 29072132)
18. Bazan N. G., Synaptic signaling by lipids in the life and death of neurons Molecular Neurobiology 2005 31 13 219 230 (Pubitemid 41271205)
19. Morley J. E., Farr S. A., Kumar V. B., Banks W. A., Alzheimer's disease through the eye of a mouse: acceptance lecture for the 2001 Gayle A. Olson and Richard D. Olson prize Peptides 2002 23 3 589 599 (Pubitemid 34143278)
20. McLaurin J., Chakrabartty A., Characterization of the interactions of Alzheimer -amyloid peptides with phospholipid membranes European Journal of Biochemistry 1997 245 2 355 363 (Pubitemid 27171258)
21. Terzi E., Holzemann G., Seelig J., Self-association of -amyloid peptide (140) in solution and binding to lipid membranes Journal of Molecular Biology 1995 252 5 633 642
22. Simakova O., Arispe N. J., The cell-selective neurotoxicity of the Alzheimer's A peptide is determined by surface phosphatidylserine and cytosolic ATP levels. Membrane binding is required for A toxicity Journal of Neuroscience 2007 27 50 13719 13729 (Pubitemid 350278273)
23. Hampton M. B., Vanags D. M., Prn-Ares M. I., Orrenius S., Involvement of extracellular calcium in phosphatidylserine exposure during apoptosis FEBS Letters 1996 399 3 277 282 (Pubitemid 26426865)
24. Rosales-Corral S. A., Acuna-Castroviejo D., Coto-Montes A., Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin Journal of Pineal Research 2012 52 2 167 202
25. Lee G., Pollard H. B., Arispe N., Annexin 5 and apolipoprotein E2 protect against Alzheimer's amyloid- -peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site Peptides 2002 23 7 1249 1263 (Pubitemid 34786704)
26. Lai Z., Coln W., Kelly J. W., The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid Biochemistry 1996 35 20 6470 6482 (Pubitemid 26164080)
27. de Planque M. R. R., Raussens V., Contera S. A., Rijkers D. T. S., Liskamp R. M. J., Ruysschaert J. M., Ryan J. F., Separovic F., Watts A., Beta-Sheet structured beta-amyloid(140) perturbs phosphatidylcholine model membranes Journal of Molecular Biology 2007 368 4 982 997 (Pubitemid 46574660)
28. Eckert G. P., Kirsch C., Leutz S., Wood W. G., Mller W. E., Cholesterol modulates amyloid beta-peptide's membrane interactions Pharmacopsychiatry 2003 36 supplement 2 S136 S143
29. Gibson Wood W., Eckert G. P., Igbavboa U., Muller W. E., Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease Biochim Biophys Acta 2003 1610 2 281 290 (Pubitemid 36324471)
30. Kakio A., Nishimoto S. I., Yanagisawa K., Kozutsumi Y., Matsuzaki K., Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid The Journal of Biological Chemistry 2001 276 27 24985 24990
31. Subasinghe S., Unabia S., Barrow C. J., Mok S. S., Aguilar M. I., Small D. H., Cholesterol is necessary both for the toxic effect of A peptides on vascular smooth muscle cells and for A binding to vascular smooth muscle cell membranes Journal of Neurochemistry 2003 84 3 471 479 (Pubitemid 36182246)
32. Buchsteiner A., Hauss T., Dante S., Dencher N. A., Alzheimer's disease amyloid-beta peptide analogue alters the ps-dynamics of phospholipid membranes Biochim Biophys Acta 2010 1798 10 1969 1976
33. Qiu L., Buie C., Reay A., Vaughn M. W., Cheng K. H., Molecular dynamics simulations reveal the protective role of cholesterol in beta-amyloid protein-induced membrane disruptions in neuronal membrane mimics Journal of Physical Chemistry B 2011 115 32 9795 9812
34. D'Errico G., Vitiello G., Ortona O., Tedeschi A., Ramunno A., D'Ursi A. M., Interaction between Alzheimer's Abeta(25-35) peptide and phospholipid bilayers: the role of cholesterol Biochim Biophys Acta 2008 1778 12 2710 2716
35. Mecocci P., Cherubini A., Beal M. F., Cecchetti R., Chionne F., Polidori M. C., Romano G., Senin U., Altered mitochondrial membrane fluidity in AD brain Neuroscience Letters 1996 207 2 129 132 (Pubitemid 26116548)
36. Chen J. J., Yu B. P., Alterations in mitochondrial membrane fluidity by lipid peroxidation products Free Radical Biology and Medicine 1994 17 5 411 418 (Pubitemid 24320290)
37. Leaden P., Barrionuevo J., Catal A., The protection of long chain polyunsaturated fatty acids by melatonin during nonenzymatic lipid peroxidation of rat liver microsomes Journal of Pineal Research 2002 32 3 129 134 (Pubitemid 34309878)
38. Feng Z., Qin C., Chang Y., Zhang J. T., Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease Free Radical Biology and Medicine 2006 40 1 101 109 (Pubitemid 41759407)
39. Gavazza M., Catal A., Melatonin preserves arachidonic and docosapentaenoic acids during ascorbate-Fe 2+ peroxidation of rat testis microsomes and mitochondria International Journal of Biochemistry and Cell Biology 2003 35 3 359 366 (Pubitemid 36084458)
40. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., Butterfield D. A., A model for -amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1994 91 8 3270 3274
41. Liang J. J., Gu C. L., Kacher M. L., Foote C. S., Chemistry of singlet oxygen. 45. Mechanism of the photooxidation of sulfides Journal of the American Chemical Society 1983 105 14 4717 4721 (Pubitemid 13571443)
42. Milton N. G. N., Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment Drugs and Aging 2004 21 2 81 100 (Pubitemid 38294378)
43. Behl C., Davis J. B., Lesley R., Schubert D., Hydrogen peroxide mediates amyloid protein toxicity Cell 1994 77 6 817 827 (Pubitemid 24187680)
44. Shi C., Wu F., Xu J., H2O2 and PAF mediate A 142-induced Ca 2+ dyshomeostasis that is blocked by EGb761 Neurochemistry International 2010 56 8 893 905
45. Manczak M., Anekonda T. S., Henson E., Park B. S., Quinn J., Reddy P. H., Mitochondria are a direct site of A accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression Human Molecular Genetics 2006 15 9 1437 1449
46. Weldon D. T., Rogers S. D., Ghilardi J. R., Finke M. P., Cleary J. P., O'Hare E., Esler W. P., Maggio J. E., Mantyh P. W., Fibrillar -amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo Journal of Neuroscience 1998 18 6 2161 2173 (Pubitemid 28141421)
47. Ishii K., Muelhauser F., Liebl U., Picard M., Kuhl S., Penke B., Bayer T., Wiessler M., Hennerici M., Beyreuther K., Hartmann T., Fassbender K., Subacute NO generation induced by Alzheimer's -amyloid in the living brain: reversal by inhibition of the inducible NO synthase The FASEB Journal 2000 14 11 1485 1489 (Pubitemid 30636553)
48. Paxinos G., The Rat Nervous System 1984 Sydney, Australia Academic Press
49. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., Protein measurement with the Folin phenol reagent The Journal of Biological Chemistry 1951 193 1 265 275
50. Engelman D. M., Rothman J. E., The planar organization of lecithin-cholesterol bilayers The Journal of Biological Chemistry 1972 247 11 3694 3697
51. Avdulov N. A., Chochina S. V., Igbavboa U., Warden C. S., Vassiliev A. V., Wood W. G., Lipid binding to amyloid -peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids Journal of Neurochemistry 1997 69 4 1746 1752 (Pubitemid 27406976)
52. Kakio A., Nishimoto S., Kozutsumi Y., Matsuzaki K., Formation of a membrane-active form of amyloid beta-protein in raft-like model membranes Biochemical and Biophysical Research Communications 2003 303 2 514 518 (Pubitemid 36349200)
53. Ginsberg L., Xuereb J. H., Gershfeld N. L., Membrane instability, plasmalogen content, and Alzheimer's disease Journal of Neurochemistry 1998 70 6 2533 2538 (Pubitemid 28252380)
54. Rosales-Corral S. A., Acuna-Castroviejo D., Tan D.-X., Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin Journal Pineal Research 2012 52 2 167 202
55. Shinitzky M., Barenholz Y., Fluidity parameters of lipid regions determined by fluorescence polarization Biochimica et Biophysica Acta 1978 515 4 367 394 (Pubitemid 9099585)
56. Pensalfini A., Zampagni M., Liguri G., Becatti M., Evangelisti E., Fiorillo C., Bagnoli S., Cellini E., Nacmias B., Sorbi S., Cecchi C., Membrane cholesterol enrichment prevents A -induced oxidative stress in Alzheimer's fibroblasts Neurobiology of Aging 2011 32 2 210 222
57. Eichner J. E., Dunn S. T., Perveen G., Thompson D. M., Stewart K. E., Stroehla B. C., Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review American Journal of Epidemiology 2002 155 6 487 495 (Pubitemid 34208040)
58. Sadowski M. J., Pankiewicz J., Scholtzova H., Mehta P. D., Prelli F., Quartermain D., Wisniewski T., Blocking the apolipoprotein E/amyloid- interaction as a potential therapeutic approach for Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2006 103 49 18787 18792 (Pubitemid 44913488)
59. Ha S., Fresser F., Kchl S., Beyreuther K., Utermann G., Baier G., Physical interaction of ApoE with amyloid precursor protein independent of the amyloid A region in vitro The Journal of Biological Chemistry 1998 273 22 13892 13897 (Pubitemid 28268442)
60. Arold S., Sullivan P., Bilousova T., Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex Acta Neuropathologica 2012 123 1 39 52
61. Fraser T., Tayler H., Love S., Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease Neurochemical Research 2010 35 3 503 513
62. LaDu M. J., Lukens J. R., Reardon C. A., Getz G. S., Association of human, rat, and rabbit apolipoprotein E with beta-amyloid Journal of Neuroscience Research 1997 49 1 9 18 (Pubitemid 27291172)
63. Amtul Z., Uhrig M., Beyreuther K., Additive effects of fatty acid mixtures on the levels and ratio of amyloid 40/42 peptides differ from the effects of individual fatty acids Journal of Neuroscience Research 2011 89 11 1795 1801
64. Langelier B., Alessandri J. M., Perruchot M. H., Guesnet P., Lavialle M., Changes of the transcriptional and fatty acid profiles in response to n-3 fatty acids in SH-SY5Y neuroblastoma cells Lipids 2005 40 7 719 728 (Pubitemid 41266311)
65. Babcock T., Helton W. S., Espat N. J., Eicosapentaenoic acid (EPA): an antiinflammatory -3 fat with potential clinical applications Nutrition 2000 16 11-12 1116 1118
66. Lynch A. M., Loane D. J., Minogue A. M., Clarke R. M., Kilroy D., Nally R. E., Roche. J., O'Connell F., Lynch M. A., Eicosapentaenoic acid confers neuroprotection in the amyloid- challenged aged hippocampus Neurobiology of Aging 2007 28 6 845 855 (Pubitemid 46589740)
67. Minogue A. M., Lynch A. M., Loane D. J., Herron C. E., Lynch M. A., Modulation of amyloid- -induced and age-associated changes in rat hippocampus by eicosapentaenoic acid Journal of Neurochemistry 2007 103 3 914 926 (Pubitemid 47568742)
68. Bernardo A., Levi G., Minghetti L., Role of the peroxisome proliferator-activated receptor- (PPAR- ) and its natural ligand 15-deoxy-(12,14)-prostaglandin J2 in the regulation of microglial functions European Journal of Neuroscience 2000 12 7 2215 2223 (Pubitemid 30497019)
69. Tang P. L., Xu M. F., Qian Z. M., Differential behaviour of cell membranes towards iron-induced oxidative damage and the effects of melatonin Biological Signals 1997 6 46 291 300 (Pubitemid 28052580)
70. Reiter R. J., Cabrera J., Sainz R. M., Mayo J. C., Manchester L. C., Tan D. X., Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and Parkinsonism Annals of the New York Academy of Sciences 1999 890 471 485 (Pubitemid 30040411)
71. Abdul H. M., Butterfield D. A., Protection against amyloid beta-peptide (142)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease Biochimica et Biophysica Acta 2005 1741 1-2 140 148 (Pubitemid 40824999)
72. Chauhan A., Ray I., Chauhan V. P. S., Interaction of amyloid beta-protein with anionic phospholipids: possible involvement of Lys28 and C-terminus aliphatic amino acids Neurochemical Research 2000 25 3 423 429 (Pubitemid 30161491)
73. Yang A. J., Chandswangbhuvana D., Shu T., Henschen A., Glabe C. G., Intracellular accumulation of insoluble, newly synthesized A n-42 in amyloid precursor protein-transfected cells that have been treated with A 1-42 The Journal of Biological Chemistry 1999 274 29 20650 20656
74. Hansson Petersen C. A., Alikhani N., Behbahani H., Wiehager B., Pavlov P. F., Alafuzoff I., Leinonen V., Ito A., Winblad B., Glaser E., Ankarcrona M., The amyloid -peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae Proceedings of the National Academy of Sciences of the United States of America 2008 105 35 13145 13150
75. Swerdlow R. H., Khan S. M., The Alzheimer's disease mitochondrial cascade hypothesis: an update Experimental Neurology 2009 218 2 308 315
76. Atamna H., Frey W. H., Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease Mitochondrion 2007 7 5 297 310 (Pubitemid 47300175)